The authors declare that they have no competing interests.
CCY reviewed the literature reviews, designed the study, and drafted the manuscript. CHH participated in the design of the study and did the statistical analysis. KFH, KTC and CL participated in the literature reviews and data interpretation. JJW involved in revising the manuscript and provided administrative technical support. CCC conceived the study, and participated in its design, in the coordination and interpretation of the data, and in the revision of the manuscript. All authors read and approved the final manuscript.
The epidemiologic profile of ethnic Chinese patients with Dupuytren’s disease is unknown. We therefore investigated the epidemiology of Dupuytren’s disease using Taiwan’s National Health Insurance Research Database.
Patients who filed claims for treatment for Dupuytren’s disease between January 2000 and December 2011 were identified in the database. Age- and gender-specific incidences were estimated by dividing the incidence number by population data.
We identified 1,078 patients with Dupuytren’s disease (681 men, 397 women; male/female ratio: 1:1.72). The annual incidence rate ranged from 0.39-0.63/105 for men and 0.14-0.44/105 for women. A trend analysis revealed a rising trend in the annual incidence from 2001 to 2011 (p = 0.0199). The prevalence rate increased steadily from 0.46/105 in 2000 to 4.52/105 in 2011 (p = 0.0186). The mean age at onset was significantly higher in men than in women (60.7 ± 18.4 vs. 53.7 ± 15.5 years). Peak age at onset for men was 70–79 (28.1%) and for women was 50–59 (33.5%). Men > 60 years old had higher incidence rates than did women (incidence rate ratios: 2.0, 4.5, and 6.6 for those 60–69, 70–79, and ≥ 80, respectively). Hypertension (29.6%), diabetes mellitus (21.9%), hyperlipidemia (14.8%), ischemic heart disease (10.5%), and chronic obstructive pulmonary disease (8.0%) were the most common comorbidities.
The incidence and prevalence of Dupuytren’s disease and the male/female ratio were significantly lower in ethnic Chinese than in Western ethnic groups. Moreover, the age at onset was significantly lower in ethnic Chinese women. However, the incidences of three comorbidities (hypertension, diabetes mellitus, and hyperlipidemia) were similar to those in other ethnicities.
Tomasek JJ, Vaughan MB, Haaksma CJ. Cellular structure and biology of Dupuytren's disease. Hand Clin. 1999;15(1):21–34. PubMed
Maravic M, Landais P. Dupuytren's disease in France–1831 to 2001–from description to economic burden. J Hand Surg. 2005;30(5):484–7. CrossRef
Burge P, Hoy G, Regan P, Milne R. Smoking, alcohol and the risk of Dupuytren's contracture. J Bone Joint Surg. 1997;79(2):206–10. CrossRef
Arkkila PE, Kantola IM, Viikari JS. Dupuytren's disease: association with chronic diabetic complications. J Rheumatol. 1997;24(1):153–9. PubMed
Bonnici AV, Birjandi F, Spencer JD, Fox SP, Berry AC. Chromosomal abnormalities in Dupuytren's contracture and carpal tunnel syndrome. J Hand Surg. 1992;17(3):349–55. CrossRef
Kelly SA, Burke FD, Elliot D. Injury to the distal radius as a trigger to the onset of Dupuytren's disease. J Hand Surg. 1992;17(2):225–9. CrossRef
Flatt AE. The Vikings and Baron Dupuytren's disease. Proceedings. 2001;14(4):378–84.
Degreef I, De Smet L. A high prevalence of Dupuytren's disease in Flanders. Acta Orthop Belg. 2010;76(3):316–20. PubMed
Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology. Hand (N Y). 2009;4(3):256–69. CrossRef
Burge P. Genetics of Dupuytren's disease. Hand Clin. 1999;15(1):63–71. PubMed
Mikkelsen OA. The prevalence of Dupuytren's disease in Norway. a study in a representative population sample of the municipality of Haugesund. Acta Chir Scand. 1972;138(7):695–700. PubMed
Liu Y, Chen WY. Dupuytren's disease among the Chinese in Taiwan. J Hand Surg. 1991;16(5):779–86. CrossRef
Gonzalez MH, Sobeski J, Grindel S, Chunprapaph B, Weinzweig N. Dupuytren's disease in African-Americans. J Hand Surg. 1998;23(3):306–7. CrossRef
Finsen V, Dalen H, Nesheim J. The prevalence of Dupuytren's disease among 2 different ethnic groups in northern Norway. J Hand Surg. 2002;27(1):115–7. CrossRef
Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. Prevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based study. Hand (N Y). 2011;6(2):149–58. CrossRef
Early PF. Population studies in dupuytren's contracture. J Bone Joint Surg Br. 1962;44-B(3):602–13.
Liu CY, Hung YT, Chuang YL, Chen YJ, Weng SW, Liu JS, et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;4(1):1–22.
Jurisic D, Kovic I, Lulic I, Stanec Z, Kapovic M, Uravic M. Dupuytren's disease characteristics in Primorsko-goranska County, Croatia. Coll Antropol. 2008;32(4):1209–13. PubMed
Khan AA, Rider OJ, Jayadev CU, Heras-Palou C, Giele H, Goldacre M. The role of manual occupation in the aetiology of Dupuytren's disease in men in England and Wales. J Hand Surg. 2004;29(1):12–4. CrossRef
Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren's disease risk factors. J Hand Surg. 2004;29(5):423–6. CrossRef
Egawa T, Senrui H, Horiki A. Dupuytren's disease in Japanese. Singapore: Longman; 1990.
Sanderson PL, Morris MA, Stanley JK, Fahmy NR. Lipids and Dupuytren's disease. J Bone Joint Surg. 1992;74(6):923–7.
Larkin JG, Frier BM. Limited joint mobility and Dupuytren's contracture in diabetic, hypertensive, and normal populations. Br Med J. 1986;292(6534):1494. CrossRef
Wilbrand S, Ekbom A, Gerdin B. The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. J Hand Surg. 1999;24(4):456–9. CrossRef
Anthony SG, Lozano-Calderon SA, Simmons BP, Jupiter JB. Gender ratio of Dupuytren's disease in the modern U.S. population. Hand (N Y). 2008;3(2):87–90. CrossRef
- Epidemiological profile of Dupuytren’s disease in Taiwan (Ethnic Chinese): a nationwide population-based study
- BioMed Central
Neu im Fachgebiet Orthopädie und Unfallchirurgie
Mail Icon II